钆塞酸增强磁共振成像与动态计算机断层扫描在局灶性肝脏病变特征描述中的个体内比较:一项多中心、多读者研究
这项回顾性多中心研究纳入217例慢性肝病患者的231个经组织学证实的肝脏病变,由4名放射科医师独立盲法阅片,按LI-RADS v2014比较钆塞酸增强MRI与动态CT的诊断效能;MRI对LR-5/5V/M分类的敏感度(72.4% vs 59.0%)和准确率(75.3% vs 65.3%)均高于CT,两者对LR-M分类的准确率无显著差异。
要点
- 钆塞酸增强MRI对肝恶性肿瘤LR-5/5V/M分类的敏感度和准确率均高于动态CT。
- 动态CT与钆塞酸增强MRI鉴别肝细胞癌与其他恶性肿瘤(LR-M)的准确率无显著差异。
- 阅片采用LI-RADS v2014,先读MRI、4周后读CT,属个体内比较设计。
核心结论
- 钆塞酸增强MRI对肝恶性肿瘤LR-5/5V/M分类的准确率优于动态CT。
- 两种方法鉴别其他恶性肿瘤与肝细胞癌的准确率相当。
研究设计与样本
- 回顾性多中心研究,纳入217例慢性肝病患者的231个经组织学证实的肝脏病变(114个肝细胞癌、58个非肝细胞癌恶性肿瘤、59个良性病变)。
- 患者来自5家三级医院之一,均接受钆塞酸增强MRI和动态CT检查。
- 4名来自不同机构的放射科医师独立阅片,先读全部MR图像,4周后读CT图像,按LI-RADS v2014评估主要和辅助影像特征并分类。
- 诊断效能采用广义估计方程计算并比较。
诊断标准与关键数值
- LR-5/5V/M分类的汇总敏感度:CT 59.0% vs MRI 72.4%(p < 0.001)。
- LR-5/5V/M分类的汇总特异度:CT 83.5% vs MRI 83.9%(p = 0.906)。
- LR-5/5V/M分类的汇总准确率:CT 65.3% vs MRI 75.3%(p < 0.001)。
- LR-M分类的汇总准确率:CT 79.9% vs MRI 82.4%(p = 0.139)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the diagnostic accuracy of dynamic computed tomography (CT) and gadoxetate-enhanced magnetic resonance imaging (MRI) for characterization of hepatic lesions by using the Liver Imaging Reporting and Data System (LI-RADS) in a multicenter, off-site evaluation.
MATERIALS AND METHODS: In this retrospective multicenter study, we evaluated 231 hepatic lesions (114 hepatocellular carcinomas [HCCs], 58 non-HCC malignancies, and 59 benign lesions) confirmed histologically in 217 patients with chronic liver disease who underwent both gadoxetate-enhanced MRI and dynamic CT at one of five tertiary hospitals. Four radiologists at different institutes independently reviewed all MR images first and the CT images 4 weeks later. They evaluated the major and ancillary imaging features and categorized each hepatic lesion according to the LI-RADS v2014. Diagnostic performance was calculated and compared using generalized estimating equations.
RESULTS: MRI showed higher sensitivity and accuracy than CT for diagnosing hepatic malignancies; the pooled sensitivities, specificities, and accuracies for categorizing LR-5/5V/M were 59.0% vs. 72.4% (CT vs. MRI; p < 0.001), 83.5% vs. 83.9% (p = 0.906), and 65.3% vs. 75.3% (p < 0.001), respectively. CT and MRI showed comparable capabilities for differentiating between HCC and other malignancies, with pooled accuracies of 79.9% and 82.4% for categorizing LR-M, respectively (p = 0.139).
CONCLUSION: Gadoxetate-enhanced MRI showed superior accuracy for categorizing LR-5/5V/M in hepatic malignancies in comparison with dynamic CT. Both modalities had comparable accuracies for distinguishing other malignancies from HCC.
引用
- An C, Lee CH, Byun JH, et al. Intraindividual Comparison between Gadoxetate-Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study. Korean J Radiol. 2019. PMID: 31854149. doi:10.3348/kjr.2019.0363
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。